A study of the efficacy of noxytiolin (cas 15599-39-0) instillation as adjunctive to radiotherapy in carcinoma of the bladder: A clinical trial
-
Add time:08/31/2019 Source:sciencedirect.com
A prospective study was conducted to establish the efficacy or otherwise of noxytiolin (cas 15599-39-0) (N-hydroxymethyl-N-methylthiorea) instilled concurrently with radical radiotherapy in bladder carcinoma, a previous pilot study having indicated an improved survival rate. A total of 242 patients participated in the trial. The four-year survival figures are compared and it is concluded that there was no significant difference between the controls and those patients treated with Noxytiolin.
We also recommend Trading Suppliers and Manufacturers of noxytiolin (cas 15599-39-0). Pls Click Website Link as below: cas 15599-39-0 suppliers
Prev:Bicyclo[3.3.1]nonane and its derivatives—IV : Reactions of some carbonyl derivatives of bicyclo[3.3.1]nonane with diazomethane
Next:NotesLiquid Chromatographic Determination of noxytiolin (cas 15599-39-0) and 1-Methyl-2-Thiourea in Serum: Application to Pharmacokinetic Studies in Rabbits and Humans) - 【Back】【Close 】【Print】【Add to favorite 】